Dynamic prediction of metastases after radical prostatectomy for prostate cancer

Brant A. Inman, Igor Frank, Stephen A. Boorjian, Joseph W. Akornor, Robert Jeffrey Karnes, Bradley C. Leibovich, Michael L. Blute, Eric J. Bergstralh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Study Type - Prognosis (retrospective cohort) Level of Evidence 2a What's known on the subject? and What does the study add? One of two problems plagues virtually are existing post-prostatectomy prediction tools: either (1) they predict PSA recurrences (which are of unclear importance) or (2) the predictions they make are anchored at the date of surgery and are not updated based on how patients evolve over the postoperative years. Our prediction tool is a significant improvement over existing prediction tools in that it predicts the development of metastases which is a very important clinical endpoint that indicates incurable prostate cancer. Additionally, our tool allows for updated predictions at any point following radical prostatectomy by considering commonly available postoperative information (postoperative serum PSA and use of adjuvant therapies) to modify its risk predictions. The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course. OBJECTIVE • To develop a dynamic algorithm that predicts the risk of metastases from any time point after radical prostatectomy (RP). PATIENTS AND METHODS • The study cohort consisted of 5741 RP patients who were treated from 1990-99. • Patients were grouped into one of four clinical states at follow-up: State 1, prostate-specific antigen (PSA) undetectable; State 2, PSA 0.15-0.39 ng/mL; State 3, PSA ≥0.4 ng/mL; and State 4, previous androgen deprivation or radiation therapy. • Follow-up epochs (alive and at risk of systemic progression) at 0, 2, 4 and 6 years post-RP, cumulative incidence curves and multistate Cox models were used to assess the risk of metastases over the ensuing 5-year interval. • Gleason score, seminal vesicle and surgical margin involvement, and PSA variables were evaluated as predictors. RESULTS • Median follow-up was 11.7 years, with 4411, 4256 and 3983 patients followed with PSA at 2, 4 and 6 years, respectively. • In total, 287 metastatic events occurred and the 5-year risk of metastasis was 0.4%, 2.1%, 8.7% and 12.6% for men in States 1, 2, 3 and 4, respectively. • Independent predictors of metastasis by group included seminal vesicle involvement (all groups), Gleason score (groups 1, 3 and 4), current PSA (groups 3 and 4) and maximum past PSA (group 4). CONCLUSIONS • We present a web-based prognostic tool for patients undergoing RP that is valid at many time points after surgery. • Our tool predicts the development of metastases.

Original languageEnglish (US)
Pages (from-to)1762-1768
Number of pages7
JournalBJU International
Volume108
Issue number11
DOIs
StatePublished - Dec 2011

Fingerprint

Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Neoplasm Metastasis
Neoplasm Grading
Seminal Vesicles
Plague
Proportional Hazards Models
Androgens
Cohort Studies
Radiotherapy
Recurrence
Incidence
Serum

Keywords

  • clinical prediction
  • metastases
  • outcome assessment
  • prostate cancer
  • prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

Inman, B. A., Frank, I., Boorjian, S. A., Akornor, J. W., Karnes, R. J., Leibovich, B. C., ... Bergstralh, E. J. (2011). Dynamic prediction of metastases after radical prostatectomy for prostate cancer. BJU International, 108(11), 1762-1768. https://doi.org/10.1111/j.1464-410X.2011.10208.x

Dynamic prediction of metastases after radical prostatectomy for prostate cancer. / Inman, Brant A.; Frank, Igor; Boorjian, Stephen A.; Akornor, Joseph W.; Karnes, Robert Jeffrey; Leibovich, Bradley C.; Blute, Michael L.; Bergstralh, Eric J.

In: BJU International, Vol. 108, No. 11, 12.2011, p. 1762-1768.

Research output: Contribution to journalArticle

Inman, BA, Frank, I, Boorjian, SA, Akornor, JW, Karnes, RJ, Leibovich, BC, Blute, ML & Bergstralh, EJ 2011, 'Dynamic prediction of metastases after radical prostatectomy for prostate cancer', BJU International, vol. 108, no. 11, pp. 1762-1768. https://doi.org/10.1111/j.1464-410X.2011.10208.x
Inman, Brant A. ; Frank, Igor ; Boorjian, Stephen A. ; Akornor, Joseph W. ; Karnes, Robert Jeffrey ; Leibovich, Bradley C. ; Blute, Michael L. ; Bergstralh, Eric J. / Dynamic prediction of metastases after radical prostatectomy for prostate cancer. In: BJU International. 2011 ; Vol. 108, No. 11. pp. 1762-1768.
@article{cdfae8923c0d43d19bc657569417fc30,
title = "Dynamic prediction of metastases after radical prostatectomy for prostate cancer",
abstract = "Study Type - Prognosis (retrospective cohort) Level of Evidence 2a What's known on the subject? and What does the study add? One of two problems plagues virtually are existing post-prostatectomy prediction tools: either (1) they predict PSA recurrences (which are of unclear importance) or (2) the predictions they make are anchored at the date of surgery and are not updated based on how patients evolve over the postoperative years. Our prediction tool is a significant improvement over existing prediction tools in that it predicts the development of metastases which is a very important clinical endpoint that indicates incurable prostate cancer. Additionally, our tool allows for updated predictions at any point following radical prostatectomy by considering commonly available postoperative information (postoperative serum PSA and use of adjuvant therapies) to modify its risk predictions. The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course. OBJECTIVE • To develop a dynamic algorithm that predicts the risk of metastases from any time point after radical prostatectomy (RP). PATIENTS AND METHODS • The study cohort consisted of 5741 RP patients who were treated from 1990-99. • Patients were grouped into one of four clinical states at follow-up: State 1, prostate-specific antigen (PSA) undetectable; State 2, PSA 0.15-0.39 ng/mL; State 3, PSA ≥0.4 ng/mL; and State 4, previous androgen deprivation or radiation therapy. • Follow-up epochs (alive and at risk of systemic progression) at 0, 2, 4 and 6 years post-RP, cumulative incidence curves and multistate Cox models were used to assess the risk of metastases over the ensuing 5-year interval. • Gleason score, seminal vesicle and surgical margin involvement, and PSA variables were evaluated as predictors. RESULTS • Median follow-up was 11.7 years, with 4411, 4256 and 3983 patients followed with PSA at 2, 4 and 6 years, respectively. • In total, 287 metastatic events occurred and the 5-year risk of metastasis was 0.4{\%}, 2.1{\%}, 8.7{\%} and 12.6{\%} for men in States 1, 2, 3 and 4, respectively. • Independent predictors of metastasis by group included seminal vesicle involvement (all groups), Gleason score (groups 1, 3 and 4), current PSA (groups 3 and 4) and maximum past PSA (group 4). CONCLUSIONS • We present a web-based prognostic tool for patients undergoing RP that is valid at many time points after surgery. • Our tool predicts the development of metastases.",
keywords = "clinical prediction, metastases, outcome assessment, prostate cancer, prostatectomy",
author = "Inman, {Brant A.} and Igor Frank and Boorjian, {Stephen A.} and Akornor, {Joseph W.} and Karnes, {Robert Jeffrey} and Leibovich, {Bradley C.} and Blute, {Michael L.} and Bergstralh, {Eric J.}",
year = "2011",
month = "12",
doi = "10.1111/j.1464-410X.2011.10208.x",
language = "English (US)",
volume = "108",
pages = "1762--1768",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Dynamic prediction of metastases after radical prostatectomy for prostate cancer

AU - Inman, Brant A.

AU - Frank, Igor

AU - Boorjian, Stephen A.

AU - Akornor, Joseph W.

AU - Karnes, Robert Jeffrey

AU - Leibovich, Bradley C.

AU - Blute, Michael L.

AU - Bergstralh, Eric J.

PY - 2011/12

Y1 - 2011/12

N2 - Study Type - Prognosis (retrospective cohort) Level of Evidence 2a What's known on the subject? and What does the study add? One of two problems plagues virtually are existing post-prostatectomy prediction tools: either (1) they predict PSA recurrences (which are of unclear importance) or (2) the predictions they make are anchored at the date of surgery and are not updated based on how patients evolve over the postoperative years. Our prediction tool is a significant improvement over existing prediction tools in that it predicts the development of metastases which is a very important clinical endpoint that indicates incurable prostate cancer. Additionally, our tool allows for updated predictions at any point following radical prostatectomy by considering commonly available postoperative information (postoperative serum PSA and use of adjuvant therapies) to modify its risk predictions. The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course. OBJECTIVE • To develop a dynamic algorithm that predicts the risk of metastases from any time point after radical prostatectomy (RP). PATIENTS AND METHODS • The study cohort consisted of 5741 RP patients who were treated from 1990-99. • Patients were grouped into one of four clinical states at follow-up: State 1, prostate-specific antigen (PSA) undetectable; State 2, PSA 0.15-0.39 ng/mL; State 3, PSA ≥0.4 ng/mL; and State 4, previous androgen deprivation or radiation therapy. • Follow-up epochs (alive and at risk of systemic progression) at 0, 2, 4 and 6 years post-RP, cumulative incidence curves and multistate Cox models were used to assess the risk of metastases over the ensuing 5-year interval. • Gleason score, seminal vesicle and surgical margin involvement, and PSA variables were evaluated as predictors. RESULTS • Median follow-up was 11.7 years, with 4411, 4256 and 3983 patients followed with PSA at 2, 4 and 6 years, respectively. • In total, 287 metastatic events occurred and the 5-year risk of metastasis was 0.4%, 2.1%, 8.7% and 12.6% for men in States 1, 2, 3 and 4, respectively. • Independent predictors of metastasis by group included seminal vesicle involvement (all groups), Gleason score (groups 1, 3 and 4), current PSA (groups 3 and 4) and maximum past PSA (group 4). CONCLUSIONS • We present a web-based prognostic tool for patients undergoing RP that is valid at many time points after surgery. • Our tool predicts the development of metastases.

AB - Study Type - Prognosis (retrospective cohort) Level of Evidence 2a What's known on the subject? and What does the study add? One of two problems plagues virtually are existing post-prostatectomy prediction tools: either (1) they predict PSA recurrences (which are of unclear importance) or (2) the predictions they make are anchored at the date of surgery and are not updated based on how patients evolve over the postoperative years. Our prediction tool is a significant improvement over existing prediction tools in that it predicts the development of metastases which is a very important clinical endpoint that indicates incurable prostate cancer. Additionally, our tool allows for updated predictions at any point following radical prostatectomy by considering commonly available postoperative information (postoperative serum PSA and use of adjuvant therapies) to modify its risk predictions. The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course. OBJECTIVE • To develop a dynamic algorithm that predicts the risk of metastases from any time point after radical prostatectomy (RP). PATIENTS AND METHODS • The study cohort consisted of 5741 RP patients who were treated from 1990-99. • Patients were grouped into one of four clinical states at follow-up: State 1, prostate-specific antigen (PSA) undetectable; State 2, PSA 0.15-0.39 ng/mL; State 3, PSA ≥0.4 ng/mL; and State 4, previous androgen deprivation or radiation therapy. • Follow-up epochs (alive and at risk of systemic progression) at 0, 2, 4 and 6 years post-RP, cumulative incidence curves and multistate Cox models were used to assess the risk of metastases over the ensuing 5-year interval. • Gleason score, seminal vesicle and surgical margin involvement, and PSA variables were evaluated as predictors. RESULTS • Median follow-up was 11.7 years, with 4411, 4256 and 3983 patients followed with PSA at 2, 4 and 6 years, respectively. • In total, 287 metastatic events occurred and the 5-year risk of metastasis was 0.4%, 2.1%, 8.7% and 12.6% for men in States 1, 2, 3 and 4, respectively. • Independent predictors of metastasis by group included seminal vesicle involvement (all groups), Gleason score (groups 1, 3 and 4), current PSA (groups 3 and 4) and maximum past PSA (group 4). CONCLUSIONS • We present a web-based prognostic tool for patients undergoing RP that is valid at many time points after surgery. • Our tool predicts the development of metastases.

KW - clinical prediction

KW - metastases

KW - outcome assessment

KW - prostate cancer

KW - prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=81255168255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255168255&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2011.10208.x

DO - 10.1111/j.1464-410X.2011.10208.x

M3 - Article

VL - 108

SP - 1762

EP - 1768

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 11

ER -